J Bacteriol Virol.  2012 Mar;42(1):69-75. 10.4167/jbv.2012.42.1.69.

Enhancement of Protein Productivity of Recombinant Hepatitis A Virus VP1 in Stably Transfected Drosophila melanogaster S2 Cells

• Jeon HB
• Park JH
• Lee HH
• Kim DH
• Lee HY
• Shon DH
• Kim W
• Chung IS

• KMID: 1434775
• DOI: http://doi.org/10.4167/jbv.2012.42.1.69

Abstract

The effect of DMSO and sodium butyrate on the production of recombinant hepatitis A virus (HAV) capsid protein VP1 was evaluated and optimized in the culture of stably transfected Drosophila melanogaster S2 cells using culture plates and spinner flasks. The effect of DMSO and sodium butyrate was also evaluated to improve the recombinant VP1 production in stably transfected Drosophila S2 cells. A production level of 0.88 mg of recombinant VP1/liter was obtained in the culture-plate culture of stably transfected S2 cells at 6 days after induction with 0.5 mM CuSO4. The supplements of 2% DMSO and 10 mM sodium butyrate at 4 days post-inoculation increased recombinant VP1 accumulation by 141 and 104%, respectively, resulting in 2.17 and 1.7 mg/liter of recombinant VP1 production. In spinner flasks, recombinant VP1 production reached maximum level at 9 days after induction with 0.5 mM CuSO4, with approximately 4.96 mg/liter of recombinant VP1 production level. When 2% DMSO or 10 mM sodium butyrate was added at 5 days post-inoculation, the recombinant VP1 production was increased to 8.35 and 5.85 mg/liter, respectively. However, the synergistic effects of DMSO and sodium butyrate were not observed. These results indicate that DMSO and/or sodium butyrate can be successfully used to improve the recombinant HAV VP1 production in culture plates and spinner flasks.

Keyword

Drosophila melanogaster S2 cells; Hepatitis A virus (HAV) VP1; Dimethysulfoxide (DMSO); Sodium butyrate; Spinner flask

MeSH Terms

Butyrates
Capsid Proteins
Dimethyl Sulfoxide
Drosophila
Drosophila melanogaster
Efficiency
Hepatitis
Hepatitis A
Hepatitis A virus
Sodium
Butyrates
Capsid Proteins
Dimethyl Sulfoxide
Sodium

Figure

• 

  Figure 1 Recombinant VP1 production in DMSO and/or sodium butyrate-supplemented culture of stably transfected S2 cells using culture plates. (A) DMSO (2%) and sodium butyrate (10 mM) were added to the cultures at 4 days post-inoculation. After 2 days incubation, recombinant VP1 expressions in medium fractions were confirmed by Western blot analysis. M: molecular weight marker, Lane 1: the medium fraction of non-treated S2 cells, Lane 2: the medium fraction of 2% DMSO-treated S2 cells, Lane 3: the medium fraction of 10 mM sodium butyrate-treated S2 cells, Lane 4: the medium fraction of 2% DMSO and 10 mM sodium butyrate-treated S2 cells, Lane 5~8: 50, 100, 250, 500 ng of purified recombinant VP1 control from S2 cells. (B) The contents of recombinant VP1 from (A) experiment were estimated and are plotted as a bar diagram. Data are reported as mean ± S.D. Statistically significant differences between treatment and control groups were determined using Student's t test (** p < 0.01).

• 

  Figure 2 Cell growth in DMSO and/or sodium butyrate-supplemented culture of stably transfected S2 cells using spinner flasks. Data are reported as mean ± S.D. Statistically significant differences between treatment and control groups were determined using Student's t test (* p < 0.05, *** p < 0.001).

• 

  Figure 3 Recombinant VP1 production in DMSO and/or sodium butyrate-supplemented culture of stably transfected S2 cells using spinner flasks. (A) DMSO (2%) and sodium butyrate (10 mM) were added to the cultures at 5 days post-inoculation. Recombinant VP1 expressions in medium fractions at 9 days post-inoculation were confirmed by Western blot analysis. Lane 1: the medium fraction of non-treated S2 cells, Lane 2: the medium fraction of 2% DMSO-treated S2 cells, Lane 3: the medium fraction of 10 mM sodium butyrate-treated S2 cells, Lane 4: the medium fraction of 2% DMSO and 10 mM sodium butyrate-treated S2 cells, Lane 5-8: 50, 100, 250, 500 ng of purified recombinant VP1 control from S2 cells. (B) The contents of recombinant VP1 from (A) experiment were estimated and are plotted as a bar diagram. Data are reported as mean ± S.D. Statistically significant differences between treatment and control groups were determined using Student's t test (* p < 0.05).

Reference

1. Hughes JV, Stanton LW, Tomassini JE, Long WJ, Scolnick EM. Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site. J Virol. 1984. 52:465–473.

2. Hughes JV, Stanton LW. Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses. J Virol. 1985. 55:395–401.

3. Stapleton JT, Lemon SM. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol. 1987. 61:491–498.

4. Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol. 1985. 55:836–839.

5. Arnon R. Synthetic peptides as the basis for vaccine design. Mol Immunol. 1991. 28:209–215.

6. Ostermayr R, von der Helm K, Gauss-Müller V, Winnacker EL, Deinhardt F. Expression of hepatitis A virus cDNA in Escherichia coli: antigenic VP1 recombinant proteins. J Virol. 1987. 61:3645–3647.

7. Johnston JM, Harmon SA, Binn LN, Richards OC, Ehrenfeld E, Summers DF. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli. J Infect Dis. 1988. 157:1203–1211.

8. Gauss-Muller V, Zhou MQ, von der Helm K, Deinhardt F. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response. J Med Virol. 1990. 31:277–283.

9. Harmon SA, Johnston JM, Ziegelhoffer T, Richards OC, Summers DF, Ehrenfeld E. Expression of hepatitis A virus capsid sequences in insect cells. Virus Res. 1988. 10:273–280.

10. Lee JM, Lee HH, Hwang-Bo J, Shon DH, Kim W, Chung IS. Expression and immunogenicity of recombinant polypeptide VP1 of human hepatitis A virus in stably transformed fruitfly (Drosophila melanogaster) Schneider 2 cells. Biotechnol Appl Biochem. 2009. 53:101–109.

11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970. 227:680–685.

12. Schmidt AJ, Lee JM, An G. Media and environmental effects on phenolics production from Tobacco cell cultures. Biotechnol Bioeng. 1989. 33:1437–1444.

13. Wahl MF, An GH, Lee JM. Effects of dimethyl sulfoxide on heavy chain monoclonal antibody production from plant cell culture. Biotechnol Lett. 1995. 17:463–468.

14. Rodriguez J, Spearman M, Huzel N, Butler M. Enhanced production of monomeric interferon-beta by CHO cells through the control of culture conditions. Biotechnol Prog. 2005. 21:22–30.

15. Li J, Sun X, Zhang Y. Improvement of hepatitis B surface antigen expression by dimethyl sulfoxide in the culture of recombinant Chinese hamster ovary cells. Process Biochem. 2006. 41:317–322.

16. Palermo DP, DeGraaf ME, Marotti KR, Rehberg E, Post LE. Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression. J Biotechnol. 1991. 19:35–47.

17. Oster T, Thioudellet C, Chevalot I, Masson C, Wellman M, Marc A, et al. Induction of recombinant human gamma-glutamyl transferase by sodium butyrate in transfected V79 and CHO Chinese hamster cells. Biochem Biophys Res Commun. 1993. 193:406–412.

18. Chang KH, Park JH, Lee YH, Kim JH, Chun HO, Kim JH, et al. Dimethylsulfoxide and sodium butyrate enhance the production of recombinant cyclooxygenase 2 in stably transformed Drosophila melanogaster S2 cells. Biotechnol Lett. 2002. 24:1353–1359.

19. Oh SK, Vig P, Chua F, Teo WK, Yap MG. Substantial overproduction of antibodies by applying osmotic pressure and sodium butyrate. Biotechnol Bioeng. 1993. 42:601–610.

20. Arts J, Lansink M, Grimbergen J, Toet KH, Kooistra T. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem J. 1995. 310:171–176.

21. Park JH, Chang KH, Lee YH, Kim HY, Yang JM, Chung IS. Production of recombinant rotavirus capsid protein VP7 from stably transformed Drosophila melanogaster S2 cells. J Microbial Biotechnol. 2002. 12:563–568.